Our disposable-syringe jet injector (DSJI) project involves collaboration with multiple DSJI developers as well as with public-sector organizations, such as the World Health Organization, the US Centers for Disease Control and Prevention, and the Brazilian Ministry of Health, and with vaccine manufacturers such as Bio-Manguinhos. We support diverse research activities, facilitate connections between industry and the public sector, and provide technical expertise.

Our approach to working with industry guides our involvement with several different DSJI developers. One such developer is PharmaJet, located in Golden, Colorado. PharmaJet is a privately held company that has developed a family of needle-free injection technologies. For more details, please see the announcement of our collaboration with PharmaJet. Another is Bioject, located in Portland, Oregon, a publicly traded (OTCBB: BJCT) developer of needle-free injection therapy systems. For more details, please see the announcement of our collaboration with Bioject.